Selected research
Industry Research
Amplicon Sequencing Industry Research Report 2026
Market perspective
The global Amplicon Sequencing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Amplicon Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Amplicon Sequencing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Amplicon Sequencing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Amplicon Sequencing include IDT, Azenta Life Sciences, Eurofins Genomics, Novogene, BGI (BGI Genomics), Macrogen, Psomagen, SeqMatic and CD Genomics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Amplicon Sequencing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Amplicon Sequencing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amplicon Sequencing Market by Company
IDT
Azenta Life Sciences
Eurofins Genomics
Novogene
BGI (BGI Genomics)
Macrogen
Psomagen
SeqMatic
CD Genomics
AllGenetics
Charles River
Source BioScience
AGRF
Plasmidsaurus
Eurofins Scientific
Charles River Laboratories
ABM
Zymo Research
Paragon Genomics
Quintara Bio
HyLabs
MUGTC
SeqCoast Genomics
Shanghai Baiqu Biomedical Technology
Illumina
Guangzhou IGE Biotechnology
Amplicon Sequencing Segment by Type
16S rDNA Sequencing
ITS Sequencing
Target Region Amplicon Sequencing
Others
Amplicon Sequencing Segment by Application
Human Health and Clinical Research
Agriculture and Food Safety
Pharmaceutical and Biotechnology Research
Forensics and Population Genetics
Others
Amplicon Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amplicon Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amplicon Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amplicon Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Amplicon Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 16S rDNA Sequencing
- ITS Sequencing
- Target Region Amplicon Sequencing
- Others
Applications
- Human Health and Clinical Research
- Agriculture and Food Safety
- Pharmaceutical and Biotechnology Research
- Forensics and Population Genetics
- Others
Companies covered
- IDT
- Azenta Life Sciences
- Eurofins Genomics
- Novogene
- BGI (BGI Genomics)
- Macrogen
- Psomagen
- SeqMatic
- CD Genomics
- AllGenetics
- Charles River
- Source BioScience
- AGRF
- Plasmidsaurus
- Eurofins Scientific
- Charles River Laboratories
- ABM
- Zymo Research
- Paragon Genomics
- Quintara Bio
- HyLabs
- MUGTC
- SeqCoast Genomics
- Shanghai Baiqu Biomedical Technology
- Illumina
- Guangzhou IGE Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Amplicon Sequencing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 16S rDNA Sequencing
- 2.2.3 ITS Sequencing
- 2.2.4 Target Region Amplicon Sequencing
- 2.2.5 Others
- 2.3 Amplicon Sequencing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Human Health and Clinical Research
- 2.3.3 Agriculture and Food Safety
- 2.3.4 Pharmaceutical and Biotechnology Research
- 2.3.5 Forensics and Population Genetics
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Amplicon Sequencing Breakdown Data by Type
- 3.1 Global Amplicon Sequencing Historic Market Size by Type (2021-2026)
- 3.2 Global Amplicon Sequencing Forecasted Market Size by Type (2027-2032)
4 Amplicon Sequencing Breakdown Data by Application
- 4.1 Global Amplicon Sequencing Historic Market Size by Application (2021-2026)
- 4.2 Global Amplicon Sequencing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Amplicon Sequencing Market Perspective (2021-2032)
- 5.2 Global Amplicon Sequencing Growth Trends by Region
- 5.2.1 Global Amplicon Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Amplicon Sequencing Historic Market Size by Region (2021-2026)
- 5.2.3 Amplicon Sequencing Forecasted Market Size by Region (2027-2032)
- 5.3 Amplicon Sequencing Market Dynamics
- 5.3.1 Amplicon Sequencing Industry Trends
- 5.3.2 Amplicon Sequencing Market Drivers
- 5.3.3 Amplicon Sequencing Market Challenges
- 5.3.4 Amplicon Sequencing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Amplicon Sequencing Players by Revenue
- 6.1.1 Global Top Amplicon Sequencing Players by Revenue (2021-2026)
- 6.1.2 Global Amplicon Sequencing Revenue Market Share by Players (2021-2026)
- 6.2 Global Amplicon Sequencing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Amplicon Sequencing Head Office and Area Served
- 6.4 Global Amplicon Sequencing Players, Product Type & Application
- 6.5 Global Amplicon Sequencing Manufacturers Established Date
- 6.6 Global Amplicon Sequencing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Amplicon Sequencing Market Size (2021-2032)
- 7.2 North America Amplicon Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Amplicon Sequencing Market Size by Country (2021-2026)
- 7.4 North America Amplicon Sequencing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Amplicon Sequencing Market Size (2021-2032)
- 8.2 Europe Amplicon Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Amplicon Sequencing Market Size by Country (2021-2026)
- 8.4 Europe Amplicon Sequencing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Amplicon Sequencing Market Size (2021-2032)
- 9.2 Asia-Pacific Amplicon Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Amplicon Sequencing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Amplicon Sequencing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Amplicon Sequencing Market Size (2021-2032)
- 10.2 South America Amplicon Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Amplicon Sequencing Market Size by Country (2021-2026)
- 10.4 South America Amplicon Sequencing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Amplicon Sequencing Market Size (2021-2032)
- 11.2 Middle East & Africa Amplicon Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Amplicon Sequencing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Amplicon Sequencing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 IDT
- 12.1.1 IDT Company Information
- 12.1.2 IDT Business Overview
- 12.1.3 IDT Revenue in Amplicon Sequencing Business (2021-2026)
- 12.1.4 IDT Amplicon Sequencing Product Portfolio
- 12.1.5 IDT Recent Developments
- 12.2 Azenta Life Sciences
- 12.2.1 Azenta Life Sciences Company Information
- 12.2.2 Azenta Life Sciences Business Overview
- 12.2.3 Azenta Life Sciences Revenue in Amplicon Sequencing Business (2021-2026)
- 12.2.4 Azenta Life Sciences Amplicon Sequencing Product Portfolio
- 12.2.5 Azenta Life Sciences Recent Developments
- 12.3 Eurofins Genomics
- 12.3.1 Eurofins Genomics Company Information
- 12.3.2 Eurofins Genomics Business Overview
- 12.3.3 Eurofins Genomics Revenue in Amplicon Sequencing Business (2021-2026)
- 12.3.4 Eurofins Genomics Amplicon Sequencing Product Portfolio
- 12.3.5 Eurofins Genomics Recent Developments
- 12.4 Novogene
- 12.4.1 Novogene Company Information
- 12.4.2 Novogene Business Overview
- 12.4.3 Novogene Revenue in Amplicon Sequencing Business (2021-2026)
- 12.4.4 Novogene Amplicon Sequencing Product Portfolio
- 12.4.5 Novogene Recent Developments
- 12.5 BGI (BGI Genomics)
- 12.5.1 BGI (BGI Genomics) Company Information
- 12.5.2 BGI (BGI Genomics) Business Overview
- 12.5.3 BGI (BGI Genomics) Revenue in Amplicon Sequencing Business (2021-2026)
- 12.5.4 BGI (BGI Genomics) Amplicon Sequencing Product Portfolio
- 12.5.5 BGI (BGI Genomics) Recent Developments
- 12.6 Macrogen
- 12.6.1 Macrogen Company Information
- 12.6.2 Macrogen Business Overview
- 12.6.3 Macrogen Revenue in Amplicon Sequencing Business (2021-2026)
- 12.6.4 Macrogen Amplicon Sequencing Product Portfolio
- 12.6.5 Macrogen Recent Developments
- 12.7 Psomagen
- 12.7.1 Psomagen Company Information
- 12.7.2 Psomagen Business Overview
- 12.7.3 Psomagen Revenue in Amplicon Sequencing Business (2021-2026)
- 12.7.4 Psomagen Amplicon Sequencing Product Portfolio
- 12.7.5 Psomagen Recent Developments
- 12.8 SeqMatic
- 12.8.1 SeqMatic Company Information
- 12.8.2 SeqMatic Business Overview
- 12.8.3 SeqMatic Revenue in Amplicon Sequencing Business (2021-2026)
- 12.8.4 SeqMatic Amplicon Sequencing Product Portfolio
- 12.8.5 SeqMatic Recent Developments
- 12.9 CD Genomics
- 12.9.1 CD Genomics Company Information
- 12.9.2 CD Genomics Business Overview
- 12.9.3 CD Genomics Revenue in Amplicon Sequencing Business (2021-2026)
- 12.9.4 CD Genomics Amplicon Sequencing Product Portfolio
- 12.9.5 CD Genomics Recent Developments
- 12.10 AllGenetics
- 12.10.1 AllGenetics Company Information
- 12.10.2 AllGenetics Business Overview
- 12.10.3 AllGenetics Revenue in Amplicon Sequencing Business (2021-2026)
- 12.10.4 AllGenetics Amplicon Sequencing Product Portfolio
- 12.10.5 AllGenetics Recent Developments
- 12.11 Charles River
- 12.11.1 Charles River Company Information
- 12.11.2 Charles River Business Overview
- 12.11.3 Charles River Revenue in Amplicon Sequencing Business (2021-2026)
- 12.11.4 Charles River Amplicon Sequencing Product Portfolio
- 12.11.5 Charles River Recent Developments
- 12.12 Source BioScience
- 12.12.1 Source BioScience Company Information
- 12.12.2 Source BioScience Business Overview
- 12.12.3 Source BioScience Revenue in Amplicon Sequencing Business (2021-2026)
- 12.12.4 Source BioScience Amplicon Sequencing Product Portfolio
- 12.12.5 Source BioScience Recent Developments
- 12.13 AGRF
- 12.13.1 AGRF Company Information
- 12.13.2 AGRF Business Overview
- 12.13.3 AGRF Revenue in Amplicon Sequencing Business (2021-2026)
- 12.13.4 AGRF Amplicon Sequencing Product Portfolio
- 12.13.5 AGRF Recent Developments
- 12.14 Plasmidsaurus
- 12.14.1 Plasmidsaurus Company Information
- 12.14.2 Plasmidsaurus Business Overview
- 12.14.3 Plasmidsaurus Revenue in Amplicon Sequencing Business (2021-2026)
- 12.14.4 Plasmidsaurus Amplicon Sequencing Product Portfolio
- 12.14.5 Plasmidsaurus Recent Developments
- 12.15 Eurofins Scientific
- 12.15.1 Eurofins Scientific Company Information
- 12.15.2 Eurofins Scientific Business Overview
- 12.15.3 Eurofins Scientific Revenue in Amplicon Sequencing Business (2021-2026)
- 12.15.4 Eurofins Scientific Amplicon Sequencing Product Portfolio
- 12.15.5 Eurofins Scientific Recent Developments
- 12.16 Charles River Laboratories
- 12.16.1 Charles River Laboratories Company Information
- 12.16.2 Charles River Laboratories Business Overview
- 12.16.3 Charles River Laboratories Revenue in Amplicon Sequencing Business (2021-2026)
- 12.16.4 Charles River Laboratories Amplicon Sequencing Product Portfolio
- 12.16.5 Charles River Laboratories Recent Developments
- 12.17 ABM
- 12.17.1 ABM Company Information
- 12.17.2 ABM Business Overview
- 12.17.3 ABM Revenue in Amplicon Sequencing Business (2021-2026)
- 12.17.4 ABM Amplicon Sequencing Product Portfolio
- 12.17.5 ABM Recent Developments
- 12.18 Zymo Research
- 12.18.1 Zymo Research Company Information
- 12.18.2 Zymo Research Business Overview
- 12.18.3 Zymo Research Revenue in Amplicon Sequencing Business (2021-2026)
- 12.18.4 Zymo Research Amplicon Sequencing Product Portfolio
- 12.18.5 Zymo Research Recent Developments
- 12.19 Paragon Genomics
- 12.19.1 Paragon Genomics Company Information
- 12.19.2 Paragon Genomics Business Overview
- 12.19.3 Paragon Genomics Revenue in Amplicon Sequencing Business (2021-2026)
- 12.19.4 Paragon Genomics Amplicon Sequencing Product Portfolio
- 12.19.5 Paragon Genomics Recent Developments
- 12.20 Quintara Bio
- 12.20.1 Quintara Bio Company Information
- 12.20.2 Quintara Bio Business Overview
- 12.20.3 Quintara Bio Revenue in Amplicon Sequencing Business (2021-2026)
- 12.20.4 Quintara Bio Amplicon Sequencing Product Portfolio
- 12.20.5 Quintara Bio Recent Developments
- 12.21 HyLabs
- 12.21.1 HyLabs Company Information
- 12.21.2 HyLabs Business Overview
- 12.21.3 HyLabs Revenue in Amplicon Sequencing Business (2021-2026)
- 12.21.4 HyLabs Amplicon Sequencing Product Portfolio
- 12.21.5 HyLabs Recent Developments
- 12.22 MUGTC
- 12.22.1 MUGTC Company Information
- 12.22.2 MUGTC Business Overview
- 12.22.3 MUGTC Revenue in Amplicon Sequencing Business (2021-2026)
- 12.22.4 MUGTC Amplicon Sequencing Product Portfolio
- 12.22.5 MUGTC Recent Developments
- 12.23 SeqCoast Genomics
- 12.23.1 SeqCoast Genomics Company Information
- 12.23.2 SeqCoast Genomics Business Overview
- 12.23.3 SeqCoast Genomics Revenue in Amplicon Sequencing Business (2021-2026)
- 12.23.4 SeqCoast Genomics Amplicon Sequencing Product Portfolio
- 12.23.5 SeqCoast Genomics Recent Developments
- 12.24 Shanghai Baiqu Biomedical Technology
- 12.24.1 Shanghai Baiqu Biomedical Technology Company Information
- 12.24.2 Shanghai Baiqu Biomedical Technology Business Overview
- 12.24.3 Shanghai Baiqu Biomedical Technology Revenue in Amplicon Sequencing Business (2021-2026)
- 12.24.4 Shanghai Baiqu Biomedical Technology Amplicon Sequencing Product Portfolio
- 12.24.5 Shanghai Baiqu Biomedical Technology Recent Developments
- 12.25 Illumina
- 12.25.1 Illumina Company Information
- 12.25.2 Illumina Business Overview
- 12.25.3 Illumina Revenue in Amplicon Sequencing Business (2021-2026)
- 12.25.4 Illumina Amplicon Sequencing Product Portfolio
- 12.25.5 Illumina Recent Developments
- 12.26 Guangzhou IGE Biotechnology
- 12.26.1 Guangzhou IGE Biotechnology Company Information
- 12.26.2 Guangzhou IGE Biotechnology Business Overview
- 12.26.3 Guangzhou IGE Biotechnology Revenue in Amplicon Sequencing Business (2021-2026)
- 12.26.4 Guangzhou IGE Biotechnology Amplicon Sequencing Product Portfolio
- 12.26.5 Guangzhou IGE Biotechnology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst